Lymphoproliferative disorder – Castleman’s disease with early childhood-onset in a child (a clinical case)

Authors

  • O. M. Mukvich SI “Institute of Pediatrics, Obstetrics and Gynecology named after academician O. Lukyanova of the National Academy of Medical Sciences of Ukraine”, Kyiv, Ukraine https://orcid.org/0000-0001-6405-4997
  • N. M. Vdovina SI “Institute of Pediatrics, Obstetrics and Gynecology named after academician O. Lukyanova of the National Academy of Medical Sciences of Ukraine”, Kyiv, Ukraine https://orcid.org/0000-0003-3949-8857
  • H. I. Klymniuk National Cancer Institute, Kyiv, Ukraine, Ukraine https://orcid.org/0000-0002-8082-0505
  • L. I. Omelchenko SI “Institute of Pediatrics, Obstetrics and Gynecology named after academician O. Lukyanova of the National Academy of Medical Sciences of Ukraine”, Kyiv, Ukraine https://orcid.org/0000-0003-2989-9278
  • T. A. Hridina SI “Institute of Pediatrics, Obstetrics and Gynecology named after academician O. Lukyanova of the National Academy of Medical Sciences of Ukraine”, Kyiv, Ukraine https://orcid.org/0000-0002-9234-9896
  • N. B. Matsiuk SI “Institute of Pediatrics, Obstetrics and Gynecology named after academician O. Lukyanova of the National Academy of Medical Sciences of Ukraine”, Kyiv, Ukraine https://orcid.org/0000-0002-1583-6543

DOI:

https://doi.org/10.14739/2310-1210.2022.6.257594

Keywords:

Castleman’s disease, lymphoproliferative syndrome, IL-6, interferon regulatory factor, genes (IRF8), children

Abstract

Castleman’s disease (angiofollicular lymphoma, giant lymph node hyperplasia, Castleman’s pseudotumor) is an understudied orphan lymphoproliferative disease with a long period of asymptomatic course and a high risk of malignancy, and variability of its clinical features can cause difficulties in diagnosis.

The aim of the study. To acquaint clinicians and increase the effectiveness of early diagnosis and treatment of Castleman’s disease (CD) in children to prevent malignancy and improve prognosis.

Results. The article presents a clinical case of CD in a 3.5-year-old boy with a long history of fever, stunted growth, sweating, arthralgia, anemia, high laboratory inflammatory factors, elevated IL-6. There was a complex diagnostic search except for infectious, immunodeficiency, autoimmune conditions. The diagnosis of hyaline-vascular type of CD was confirmed by immunohistochemical examination after lymph node excisional biopsy. Rapid positive dynamics was noted after radical removal of the lymph node conglomerate. At follow-up after 8 months, the patient met criteria for clinical and laboratory remission.

Conclusions. Castleman’s disease should be included in the search algorithm for lymphoproliferative diseases. Determining the role of genetic mutations in interferon regulatory factor (IRF8) is of scientific interest to clarify the etiology of this disease.

Author Biographies

O. M. Mukvich, SI “Institute of Pediatrics, Obstetrics and Gynecology named after academician O. Lukyanova of the National Academy of Medical Sciences of Ukraine”, Kyiv

MD, PhD, DSc, Professor, Head of the Department of Pediatric Rheumatology and Auto-inflammatory Diseases

N. M. Vdovina, SI “Institute of Pediatrics, Obstetrics and Gynecology named after academician O. Lukyanova of the National Academy of Medical Sciences of Ukraine”, Kyiv

MD, pediatrician, pediatric cardiorheumatologist

H. I. Klymniuk, National Cancer Institute, Kyiv, Ukraine

MD, PhD, pediatric oncologist, Head of the Research Department of Pediatric Oncology, Chief Specialist of the Ministry of Health of Ukraine in the specialty “Pediatric Oncology”

L. I. Omelchenko, SI “Institute of Pediatrics, Obstetrics and Gynecology named after academician O. Lukyanova of the National Academy of Medical Sciences of Ukraine”, Kyiv

MD, PhD, DSc, Professor, Senior Researcher of the Department of Pediatric Rheumatology and Auto-inflammatory Diseases, Honored Worker of Science and Technology of Ukrainе

T. A. Hridina, SI “Institute of Pediatrics, Obstetrics and Gynecology named after academician O. Lukyanova of the National Academy of Medical Sciences of Ukraine”, Kyiv

MD, PhD, ultrasound diagnostics specialist

N. B. Matsiuk, SI “Institute of Pediatrics, Obstetrics and Gynecology named after academician O. Lukyanova of the National Academy of Medical Sciences of Ukraine”, Kyiv

MD, pediatrician

References

Wall, D. A. (2019). Lymphoproliferative Disorders: Background, Pathophysiology, Epidemiology. Medscape.com. https://emedicine.medscape.com/article/987765-overview

Vyhovska Ya. I., Yevstakhevych I. Y., Maslyak Z. V., Semerak M. M., Yevstakhevych Yu. L., Knysh N. V., & Tkhir Kh. R. (2021). Klinichnyi vypadok khvoroby Kastlemana z urazhenniam pechinky ta selezinky [Clinical case of Castleman's disease with liver and spleen]. Ukrainskyi pulmonolohichnyi zhurnal, (5), 67-69. [in Ukrainian]. https://doi.org/10.32471/umj.1680-3051.145.216638

Opanasenko, N. S., Konik, B. N., Liskina, I. V., Tereshkovуch, A. V., Levanda, L. I., Zagaba L. M., & Shamray, M. Y. (2020). Klinichnyi vypadok khvoroby Kastlemana Castleman`s disease: the clinical case [Clinical case of Castleman's disease]. Ukrainskyi pulmonolohichnyi zhurnal, (3), 63-67. [in Ukrainian]. https://doi.org/10.31215/2306-4927-2020-109-3-63-67

Farruggia, P., Trizzino, A., Scibetta, N., Cecchetto, G., Guerrieri, P., D’Amore, E. S., & D'Angelo, P. (2011). Castleman’s disease in childhood: report of three cases and review of the literature. Italian journal of pediatrics, 37, 50. https://doi.org/10.1186/1824-7288-37-50

Ashjaei, B., Ghamari Khameneh, A., & Darban Hosseini Amirkhiz, G. (2020). Abdominal Mass Caused Failure to Thrive in a Young Boy: Mixed-Type Localized Retroperitoneal Castleman Disease. Case reports in oncology, 13(2), 853–856. https://doi.org/10.1159/000508531

Wojtyś, M., Piekarska, A., Kunc, M., Ptaszyński, K., Biernat, W., Zaucha, J. M., Waloszczyk, P., Lisowski, P., Kubisa, B., & Grodzki, T. (2019). Clinicopathological comparison and therapeutic approach to Castleman disease-a case-based review. Journal of thoracic disease, 11(11), 4859–4874. https://doi.org/10.21037/jtd.2019.10.73

Van Rhee, F., Oksenhendler, E., Srkalovic, G., Voorhees, P., Lim, M., Dispenzieri, A., Ide, M., Parente, S., Schey, S., Streetly, M., Wong, R., Wu, D., Maillard, I., Brandstadter, J., Munshi, N., Bowne, W., Elenitoba-Johnson, K. S., Fössa, A., Lechowicz, M. J., Chandrakasan, S., … Fajgenbaum, D. C. (2020). International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease. Blood advances, 4(23), 6039–6050. https://doi.org/10.1182/bloodadvances.2020003334

Butzmann, A., Kumar, J., Sridhar, K., Gollapudi, S., & Ohgami, R. S. (2021). A Review of Genetic Abnormalities in Unicentric and Multicentric Castleman Disease. Biology, 10(4), 251. https://doi.org/10.3390/biology10040251

Borocco, C., Ballot-Schmit, C., Ackermann, O. et al. (2020). The French paediatric cohort of Castleman disease: a retrospective report of 23 patients. Orphanet J Rare Dis 15, 95 https://doi.org/10.1186/s13023-020-1345-5

Smith, C., Lee-Miller, C., Dishop, M. K., Cost, C., Wang, M., & Asturias, E. J. (2014). Multicentric Castleman disease presenting with fever. The Journal of pediatrics, 165(6), 1261–1265. https://doi.org/10.1016/j.jpeds.2014.08.042

Nagy, A., Bhaduri, A., Shahmarvand, N., Shahryari, J., Zehnder, J. L., Warnke, R. A., Mughal, T., Ali, S., & Ohgami, R. S. (2018). Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas. Blood advances, 2(5), 481–491. https://doi.org/10.1182/bloodadvances.2017009654

Li, Z., Lan, X., Li, C., Zhang, Y., Wang, Y., Xue, W., Lu, L., Jin, M., Zhou, Z., Wang, X., Li, L., Zhang, L., Li, X., Fu, X., Sun, Z., Wu, J., Zhang, X., Yu, H., Nan, F., Chang, Y., … Zhang, M. (2019). Recurrent PDGFRB mutations in unicentric Castleman disease. Leukemia, 33(4), 1035–1038. https://doi.org/10.1038/s41375-018-0323-6

Endo, Y., Koga, T., Otaki, H., Sasaki, D., Sumiyoshi, R., Furukawa, K., Tanaka, Y., Katsunori, Y., & Kawakami, A. (2021). Idiopathic multicentric Castleman disease with novel heterozygous Ile729Met mutation in exon 10 of familial Mediterranean fever gene. Rheumatology (Oxford, England), 60(1), 445–450. https://doi.org/10.1093/rheumatology/keaa269

Van Nieuwenhove, E., Humblet-Baron, S., Van Eyck, L., De Somer, L., Dooley, J., Tousseyn, T., Hershfield, M., Liston, A., & Wouters, C. (2018). ADA2 Deficiency Mimicking Idiopathic Multicentric Castleman Disease. Pediatrics, 142(3), e20172266. https://doi.org/10.1542/peds.2017-2266

Hambleton, S., Salem, S., Bustamante, J., Bigley, V., Boisson-Dupuis, S., Azevedo, J., Fortin, A., Haniffa, M., Ceron-Gutierrez, L., Bacon, C. M., Menon, G., Trouillet, C., McDonald, D., Carey, P., Ginhoux, F., Alsina, L., Zumwalt, T. J., Kong, X. F., Kumararatne, D., Butler, K., … Gros, P. (2011). IRF8 mutations and human dendritic-cell immunodeficiency. The New England journal of medicine, 365(2), 127–138. https://doi.org/10.1056/NEJMoa1100066

McQuaid, D. C., Panse, G., Wang, W.-L., Pinkus, G. S., Katz, S. G., & Xu, M. L. (2022). Global assessment of IRF8 as a novel cancer biomarker. Human Pathology, 122, 1–10. https://doi.org/10.1016/j.humpath.2022.01.004

Rabinowitz, M. R., Levi, J., Conard, K., & Shah, U. K. (2013). Castleman disease in the pediatric neck: a literature review. Otolaryngology--head and neck surgery, 148(6), 1028-1036. https://doi.org/10.1177/0194599813479931

Pierson, S. K., Khor, J. S., Ziglar, J., Liu, A., Floess, K., NaPier, E., Gorzewski, A. M., Tamakloe, M. A., Powers, V., Akhter, F., Haljasmaa, E., Jayanthan, R., Rubenstein, A., Repasky, M., Elenitoba-Johnson, K., Ruth, J., Jacobs, B., Streetly, M., Angenendt, L., Patier, J. L., … Fajgenbaum, D. C. (2020). ACCELERATE: A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare Disorder. Cell reports. Medicine, 1(9), 100158. https://doi.org/10.1016/j.xcrm.2020.100158

Van Rhee, F., Voorhees, P., Dispenzieri, A., Fosså, A., Srkalovic, G., Ide, M., Munshi, N., Schey, S., Streetly, M., Pierson, S. K., Partridge, H. L., Mukherjee, S., Shilling, D., Stone, K., Greenway, A., Ruth, J., Lechowicz, M. J., Chandrakasan, S., Jayanthan, R., Jaffe, E. S., … Fajgenbaum, D. C. (2018). International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood, 132(20), 2115-2124. https://doi.org/10.1182/blood-2018-07-862334

Petty, R. E., Southwood, T. R., Manners, P., Baum, J., Glass, D. N., Goldenberg, J., He, X., Maldonado-Cocco, J., Orozco-Alcala, J., Prieur, A. M., Suarez-Almazor, M. E., Woo, P., & International League of Associations for Rheumatology (2004). International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. The Journal of rheumatology, 31(2), 390–392.

Downloads

Published

2022-12-20

How to Cite

1.
Mukvich OM, Vdovina NM, Klymniuk HI, Omelchenko LI, Hridina TA, Matsiuk NB. Lymphoproliferative disorder – Castleman’s disease with early childhood-onset in a child (a clinical case). Zaporozhye medical journal [Internet]. 2022Dec.20 [cited 2024Apr.19];24(6):754-9. Available from: http://zmj.zsmu.edu.ua/article/view/257594

Issue

Vol. 24 No. 6 (2022)

Section

Case Reports

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.  Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)